Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Nonparametric Estimation from Incomplete Observations

1958 • 37,219 citations

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1982 • 10,605 citations

Nonparametric Estimation from Incomplete Observations

1958 • 7,673 citations

Evaluation of survival data and two new rank order statistics arising in its consideration.

1966 • 7,595 citations

CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

2002 • 5,269 citations

Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas

1999 • 3,484 citations

A predictive model for aggressive non-Hodgkin's lymphoma

1993 • 3,483 citations

World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997

1999 • 3,357 citations

MACOP-B Chemotherapy for the Treatment of Diffuse Large-Cell Lymphoma

1985 • 677 citations

Survival Benefit of High-Dose Therapy in Poor-Risk Aggressive Non-Hodgkin’s Lymphoma: Final Analysis of the Prospective LNH87–2 Protocol—A Groupe d’Etude des Lymphomes de l’Adulte Study

2000 • 441 citations

Prognostic significance of actual dose intensity in diffuse large-cell lymphoma: results of a tree-structured survival analysis.

1990 • 428 citations

Non-Hodgkin's lymphoma time trends: United States and international data.

1992 • 363 citations

Comparison of a Second-Generation Combination Chemotherapeutic Regimen (m-BACOD) with a Standard Regimen (CHOP) for Advanced Diffuse Non-Hodgkin's Lymphoma

1992 • 331 citations

Applied categorical data analysis

1987 • 314 citations

Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy.

1995 • 288 citations

Risk Factors, Treatment, and Outcome of Central Nervous System Recurrence in Adults With Intermediate-Grade and Immunoblastic Lymphoma

1998 • 286 citations

Identification of Major Prognostic Subgroups of Patients with Large-Cell Lymphoma Treated with m-BACOD or M-BACOD

1986 • 282 citations

LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma.

1989 • 268 citations

Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial.

1991 • 222 citations

Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: A GELA study on 974 patients

2000 • 208 citations

Concepts in use of high-dose methotrexate therapy

1996 • 185 citations

Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: Application to LNH-87 protocol

1993 • 166 citations

Prognosis and treatment of lymphoblastic lymphoma in adults: a report on 80 patients.

1992 • 127 citations

The role of dose intensity in determining outcome in intermediate-grade non-Hodgkin's lymphoma.

1991 • 118 citations

Placebo-Controlled phase III Study of lenograstim (Glycosylated recombinant human granulocyte colony-Stimulating factor) in Aggressive non-Hodgkin's lymphoma: Factors influencing chemotherapy administration

1997 • 93 citations

Intensive chemotherapy in aggressive lymphomas: updated results of LNH- 80 protocol and prognostic factors affecting response and survival

1987 • 72 citations

Randomized Comparison of ACVBP and m-BACOD in the Treatment of Patients With Low-Risk Aggressive Lymphoma: The LNH87-1 Study

2000 • 69 citations

Escalated as Compared with Standard Doses of Doxorubicin in BACOP Therapy for Patients with Non-Hodgkin's Lymphoma

1993 • 64 citations

CHOP versus MACOP-B in aggressive lymphoma - a Nordic Lymphoma Group randomised trial

1999 • 60 citations

Applied Categorical Data Analysis

1988 • 51 citations

CHOP vs. ProMACE‐CytaBOM in the treatment of aggressive non‐Hodgkin's lymphomas: long‐term results of a multicenter randomized trial

1996 • 37 citations

Phase III Comparative Trial Uisng CHOP vs CIOP in the Treatment of Advanced Intermediate-Grade Non-Hodgkin's Lymphoma

1995 • 29 citations

Non-Hodgkin's Lymphoma: An analysis of the Metropolitan Detroit SEER Database

2000 • 29 citations

A Randomised British National Lymphoma Investigation trial of CHOP vs. a weekly multi-agent regimen (PACEBOM) in patients with histologically aggressive non-Hodgkin's lymphoma

2000 • 29 citations

Is the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients? A case-controlled analysis. The Groupe d'Etude des Lymphomes de l'Adulte.

1996 • 26 citations

A randomized comparison of methotrexate dose and the addition of bleomycin to chop therapy for diffuse large cell lymphoma and other non-Hodgkin's lymphomas cancer and leukemia group B study 7851

1990 • 23 citations

Long-term survival advantage of MACOP-B over CHOP in intermediate-grade non-Hodgkin's lymphoma. The Australian and New Zealand Lymphoma Group.

1997 • 19 citations

Outcome is not improved by the use of alternating chemotherapy in elderly patients with aggressive lymphoma

2001 • 13 citations